T. Kamura

H. Cai, T. Kamura, J. Nam, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Enhancement of humoral and cell mediated immune response to HPV16 L1-derived peptides subsequent to vaccination with prophylactic bivalent HPV L1 virus-like particle vaccine in healthy females.

K. Ushijima, T. Sasada, S. Shichijo, 2017, Experimental and therapeutic medicine.

Remission of metastatic cervical adenocarcinoma with weekly paclitaxel.

K. Ushijima, T. Kamura, T. Sugiyama, 2001, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Personalized peptide vaccination for cervical cancer patients who have received prior platinum-based chemotherapy

K. Ushijima, Kayoko Waki, K. Itoh, 2015, Cancer science.

Immunological evaluation of vaccination with pre-designated peptides frequently selected as vaccine candidates in an individualized peptide vaccination regimen.

K. Ushijima, Yuji Sato, S. Todo, 2004, International journal of oncology.

Primary leiomyoma of the ovary--a report of 2 resected cases.

M. Kojiro, T. Kamura, Naoyo Nishida, 2003, The Kurume medical journal.

Optimization of a novel nylon mesh container for human embryo ultrarapid vitrification.

T. Kamura, A. Nakashima, Megumu Ito, 2010, Fertility and sterility.

Molecular pathology of atypical polypoid adenomyoma of the uterus.

X. Matías-Guiu, J. Prat, T. Kamura, 2003, Human pathology.

RECQL1 DNA Repair Helicase: A Potential Therapeutic Target and a Proliferative Marker against Ovarian Cancer

K. Ushijima, Y. Furuichi, T. Kamura, 2013, PloS one.

Race and nodal disease status are prognostic factors in patients with stage IVB cervical cancer

K. Ushijima, R. Coleman, S. Westin, 2018, Oncotarget.

Treatment of patients with advanced ovarian carcinoma with massive pleural effusions

H. Nakano, Toshiaki Saito, T. Kamura, 1991, International Journal of Gynecologic Cancer.

Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan

Kazuhiro Yoshida, Y. Maehara, K. Hirata, 2015, International Journal of Clinical Oncology.

Humoral Responses to Peptides Correlate with Overall Survival in Advanced Cancer Patients Vaccinated with Peptides Based on Pre-existing, Peptide-Specific Cellular Responses

K. Shirouzu, H. Yamana, Yuji Sato, 2004, Clinical Cancer Research.

Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer

H. Chung, Soon‐Beom Kang, M. Takeuchi, 2018, British Journal of Cancer.

Assessment of MR Imaging as a Tool to Differentiate between the Major Histological Types of Uterine Sarcomas.

T. Kamura, T. Abe, H. Yano, 2015, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women.

H. Tsuda, Tsuyoshi Saito, M. Hatae, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome.

H. Tsuda, H. Yoshikawa, T. Kaku, 2001, Cancer letters.

The grading of lymphovascular space invasion in endometrial carcinoma

T. Kawarabayashi, T. Kaku, T. Iwasaka, 1999, Cancer.

Predicting pelvic lymph node metastasis in endometrial carcinoma.

T. Kaku, H. Nakano, H. Nakano, 1999, Gynecologic oncology.

Association of endometrial epithelial metaplasias with endometrial carcinoma and hyperplasia in Japanese and American women.

T. Kaku, H. Nakano, H. Nakano, 1993, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Controversies surrounding type III radical abdominal hysterectomy and its procedure using new instruments

K. Ushijima, T. Kamura, N. Tsuda, 2012 .

Reply: ‘Comment on Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)'

T. Kasamatsu, H. Yoshikawa, T. Yasugi, 2013, British Journal of Cancer.

Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206.

M. Hatae, H. Yoshikawa, T. Onda, 2009, Gynecologic oncology.

Docetaxel/irinotecan combination chemotherapy in platinum/taxane-refractory and -resistant ovarian cancer: JGOG/WJGOG Intergroup Study

K. Ushijima, T. Kamura, K. Ochiai, 2013, International Journal of Clinical Oncology.

Cytological nuclear atypia classification can predict prognosis in patients with endometrial cancer

K. Ushijima, S. Hattori, T. Kamura, 2015, Cytopathology : official journal of the British Society for Clinical Cytology.

Cytological nuclear atypia classification can predict prognosis in endometrial cancer patients

K. Ushijima, S. Hattori, T. Kamura, 2015 .

Radiation effects on DNA content of cervical cancer cells: A rapid evaluation of radiation sensitivity by laser scanning cytometry.

K. Ushijima, T. Kaku, T. Kamura, 2015, Molecular and clinical oncology.

Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour.

T. Kasamatsu, N. Sakuragi, Tsuyoshi Saito, 2015, European journal of cancer.

Clinicopathological prognostic factors and the role of cytoreduction in surgical stage IVb endometrial cancer: a retrospective multi-institutional analysis of 248 patients in Japan.

T. Kasamatsu, H. Yoshikawa, I. Konishi, 2012, Gynecologic oncology.

Weekly 1 hour paclitaxel infusion in patients with recurrent gynecological tumors: a pilot study.

K. Ushijima, T. Kamura, T. Sugiyama, 2001, Japanese journal of clinical oncology.

Identification of B cell epitopes reactive to human papillomavirus type-16L1- derived peptides

K. Ushijima, S. Hattori, T. Sasada, 2012, Virology Journal.

Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A).

T. Kasamatsu, H. Yoshikawa, T. Onda, 2015, Gynecologic oncology.

Potential of human lymph node cells for antitumor activity mediated by interferon gamma

H. Nakano, Toshiaki Saito, T. Kamura, 1991, Cancer.

Histopathological factors influencing pelvic lymph node metastases in two ormore sites in patients with cervical carcinoma undergoing radical hysterectomy

T. Kaku, H. Nakano, T. Saito, 1999, Acta obstetricia et gynecologica Scandinavica.

PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy

Mitsuaki Suzuki, J. Kigawa, H. Itamochi, 2002, International journal of cancer.

A novel tumor‐associated antigen expressed in human uterine and ovarian carcinomas

T. Kaku, H. Nakano, M. Nakashima, 1996, Cancer.

Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602.

T. Kasamatsu, K. Ushijima, H. Yoshikawa, 2016, European journal of cancer.

Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial.

A. Okamoto, T. Kasamatsu, K. Ushijima, 2020, European journal of cancer.

The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix.

T. Kaku, H. Nakano, T. Hirakawa, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias.

T. Kaku, H. Nakano, M. Nakashima, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Malignant trophoblastic neoplasms with different modes of origin.

N. Sakuragi, N. Wake, H. Nakano, 1995, Cancer genetics and cytogenetics.

Expression of Tumor‐rejection Antigens in Gynecologic Cancers

M. Sakamoto, S. Shichijo, K. Itoh, 2000, Japanese journal of cancer research : Gann.

The promotion of invasion through the basement membrane of cervical carcinoma cells by fibronectin as a chemoattractant.

H. Nakano, T. Saito, K. Sonoda, 1994, Cancer letters.

Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection.

M. Hatae, S. Nakagawa, H. Yoshikawa, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Relationship between paraaortic lymph node involvement and intraperitoneal spread in patients with ovarian cancer--a multivariate analysis.

T. Kaku, H. Nakano, T. Saito, 1993, Gynecologic oncology.

UDP-Gal: βGlcNAc β1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumour antigen recognised by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumour

S. Shichijo, K. Itoh, T. Kamura, 2002, British Journal of Cancer.

Chemotherapy for advanced or recurrent cervical cancer.

K. Ushijima, T. Kamura, 2013, Taiwanese journal of obstetrics & gynecology.

A phase III trial of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in stage IVB, persistent or recurrent cervical cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505).

H. Yoshikawa, I. Konishi, T. Kamura, 2010, Japanese journal of clinical oncology.

Early adenocarcinoma of the uterine cervix.

T. Kaku, H. Nakano, T. Saito, 1997, Gynecologic oncology.

Co-expression of Y box-binding protein-1 and P-glycoprotein as a prognostic marker for survival in epithelial ovarian cancer.

K. Ushijima, K. Kohno, T. Kamura, 2004, Gynecologic oncology.

Emergence of higher levels of invasive and metastatic properties in the drug resistant cancer cell lines after the repeated administration of cisplatin in tumor-bearing mice

T. Kaku, H. Nakano, T. Kamura, 1998, Journal of Cancer Research and Clinical Oncology.

Efficacy of second‐look laparotomy for patients with epithelial ovarian carcinoma

T. Kaku, H. Nakano, T. Saito, 1990, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

T. Kasamatsu, K. Ushijima, H. Yoshikawa, 2014 .

Prevention of lymphocele development in gynecologic cancers by the electrothermal bipolar vessel sealing device

K. Ushijima, T. Kamura, N. Tsuda, 2014, Journal of gynecologic oncology.

A case of minimal uterine serous carcinoma with distant lymph node metastasis without peritoneal dissemination

K. Ushijima, T. Kamura, K. Kawano, 2011, Journal of gynecologic oncology.

Reassessment of Myometrial Invasion in Endometrial Carcinoma

T. Kaku, T. Kamura, N. Tsukamoto, 1994, Obstetrics and gynecology.

Expression of MAGE‐1, MAGE‐2, MAGE‐3/‐6 and MAGE‐4A/‐4B genes in ovarian tumors

S. Shichijo, Y. Imai, K. Itoh, 1995, International journal of cancer.

Fertility‐preserving treatment for patients with malignant germ cell tumors of the ovary

K. Ushijima, T. Kamura, S. Nishio, 2006, The journal of obstetrics and gynaecology research.

Prophylactic chemotherapy for hydatidiform mole five to 15 years follow‐up

Y. Nose, H. Sugimori, H. Nakano, 1986, Cancer.

Adjuvant Chemotherapy After Radical Hysterectomy for Cervical Carcinoma: A Comparison With Effects of Adjuvant Radiotherapy

T. Iwasaka, M. Yokoyama, H. Sugimori, 1998, Obstetrics and gynecology.

The prognostic significance of lymphovascular space invasion in endometrial cancer when conventional hemotoxylin and eosin staining is compared to immunohistochemical staining.

M. Tsuneyoshi, T. Kaku, H. Nakano, 1995, Gynecologic oncology.

Adenoma malignum of the uterine cervix detected by imaging methods in a patient with Peutz-Jeghers syndrome.

T. Kaku, H. Nakano, T. Kamura, 1994, Gynecologic oncology.

Lymph nodes in gynecologic oncology: Enduring importance and challenge

T. Kamura, 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Management of lymph nodes in the treatment of gynecologic cancers

T. Kamura, 2007, International Journal of Clinical Oncology.

Status of treatment for the overall population of patients with stage IVb endometrial cancer, and evaluation of the role of preoperative chemotherapy: a retrospective multi-institutional study of 426 patients in Japan.

T. Kasamatsu, M. Hatae, H. Yoshikawa, 2013, Gynecologic oncology.

Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study

K. Ushijima, T. Kamura, N. Tsuda, 2013, Journal of gynecologic oncology.

Microscopic ovarian metastasis of the uterine cervical cancer.

T. Kaku, H. Nakano, T. Saito, 1991, Gynecologic oncology.

Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602.

A. Sato, H. Yoshikawa, T. Onda, 2008, Japanese journal of clinical oncology.

The history of the Gynecologic Cancer Study Group (GCSG) of the Japan Clinical Oncology Group (JCOG).

H. Yoshikawa, T. Onda, I. Konishi, 2011, Japanese journal of clinical oncology.

Feasibility study of neoadjuvant chemotherapy followed by interval cytoreductive surgery for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206.

H. Yoshikawa, T. Onda, T. Kamura, 2004, Japanese journal of clinical oncology.

Efficacy of Selective Venous Sampling to Localize a Small Ovarian Androgen‐Producing Tumor

H. Nakano, S. Amada, T. Kamura, 1999, The journal of obstetrics and gynaecology research.

Long Survival in a Rare Case of Hepatocellular Carcinoma that Metastasizedto the Ovary: A Case Report

K. Ushijima, T. Kamura, M. Kage, 2013 .

The prognostic value of semiquantitative nuclear grading in endometrial carcinomas.

T. Kawarabayashi, M. Tsuneyoshi, T. Iwasaka, 1997, Gynecologic oncology.

The problem of stage Ia (FIGO, 1985) carcinoma of the uterine cervix.

T. Kaku, T. Saito, T. Kamura, 1989, Gynecologic oncology.

The significance of peritoneal cytology in uterine cervix and endometrial cancer.

T. Kaku, T. Kamura, H. Sakai, 1997, Gynecologic oncology.

Prognostic factors from a randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer: Japan Clinical Oncology Group (JCOG) trial: JCOG0505-S1

K. Ushijima, H. Yoshikawa, I. Konishi, 2016, Cancer Chemotherapy and Pharmacology.

Distribution of basement membrane antigens in the uterine cervical adenocarcinomas: an immunohistochemical study.

T. Kaku, H. Nakano, T. Saito, 1990, Gynecologic oncology.

Rhabdomyosarcoma Originating From an Ovarian Immature Teratoma

M. Tsuneyoshi, H. Nakano, S. Amada, 1995 .

Choriocarcinoma in mother and fetus.

T. Kamura, N. Tsukamoto, K. Baba, 1986, Gynecologic oncology.

Identification of persistent trophoblastic diseases based on a human chorionic gonadotropin regression curve by means of a stepwise piecewise linear regression analysis after the evacuation of uneventful moles.

T. Kaku, H. Nakano, T. Saito, 1998, Gynecologic oncology.

Modified VAB-3 combination chemotherapy of advanced and recurrent endodermal sinus tumors of the ovary.

T. Saito, T. Kamura, N. Tsukamoto, 1985, Gynecologic oncology.

Cytologic findings in peritoneal fluids from patients with ovarian serous adenocarcinoma

T. Kamura, T. Matsuyama, N. Tsukamoto, 1986, Diagnostic cytopathology.

Malignant ovarian tumors associated with pregnancy: Report of six cases

T. Kaku, T. Saito, T. Kamura, 1989, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Antiproliferative Effects of Interferon-αCon1 on Ovarian Clear Cell Adenocarcinoma In vitro and In vivo

M. Kojiro, T. Kamura, Naoyo Nishida, 2004, Clinical Cancer Research.

Ovarian mucinous cystadenocarcinoma with sarcoma-appearing mural nodule of anaplastic carcinoma.

T. Kaku, H. Nakano, T. Saito, 1993, Gynecologic oncology.

Asian society of gynecologic oncology workshop 2010.

Young Tae Kim, J. W. Kim, H. Ngan, 2010, Journal of gynecologic oncology.

Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study.

K. Ariyoshi, T. Kaku, H. Nakano, 2000, Gynecologic oncology.

Fetomaternal hemorrhage with intraplacental chorioangioma

D. Hori, T. Kamura, K. Shimamatsu, 2013, The journal of obstetrics and gynaecology research.

Clinical characteristics of clear cell carcinoma of the ovary

Mitsuaki Suzuki, J. Kigawa, N. Terakawa, 2000, Cancer.

Is nuclear expression of Y box‐binding protein‐1 a new prognostic factor in ovarian serous adenocarcinoma?

K. Kohno, M. Kuwano, H. Nakano, 1999, Cancer.

Assessment of 99mTc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study

K. Ushijima, S. Kurata, H. Kaida, 2015, Annals of Nuclear Medicine.

Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancer.

T. Kasamatsu, H. Tsuda, K. Ushijima, 2014, Gynecologic oncology.

The role of nuclear Y-box binding protein 1 as a global marker in drug resistance.

K. Yasumoto, Y. Iwamoto, Y. Oda, 2004, Molecular cancer therapeutics.

Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer

K. Kohno, M. Kuwano, T. Hirakawa, 2002, Journal of Cancer Research and Clinical Oncology.

Endometrial carcinoma associated with hyperplasia.

T. Kaku, H. Nakano, T. Hirakawa, 1996, Gynecologic oncology.

Phase II trial of oral etoposide plus intravenous irinotecan in patients with platinum-resistant and taxane-pretreated ovarian cancer (JCOG0503).

M. Yunokawa, I. Konishi, T. Kamura, 2015, Gynecologic oncology.

DNA polymorphism analysis of a pure non-gestational choriocarcinoma of the ovary: case report.

N. Wake, H. Nakano, T. Arima, 2000, European journal of gynaecological oncology.

Polypoid endocervical adenomyoma of the uterus: A case report with MR imaging and pathological analyses

K. Ushijima, T. Kamura, S. Nishio, 2008 .

Polypoid endocervical adenomyoma: A case report with clinicopathologic analyses

K. Ushijima, T. Kamura, S. Nishio, 2007, The journal of obstetrics and gynaecology research.

Sclerosing stromal tumor of the ovary: a clinicopathologic, immunohistochemical, ultrastructural, and cytogenetic analysis with special reference to its vasculature.

M. Tsuneyoshi, S. Kawauchi, T. Kaku, 1998, The American journal of surgical pathology.

Endometrial Metaplasia Associated With Endometrial Carcinoma

T. Kaku, T. Kamura, N. Tsukamoto, 1992, Obstetrics and gynecology.

Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy

H. Nakano, T. Kamura, Toshiaki Saito, 1992, Cancer.

Analysis of gastric-type mucinous carcinoma of the uterine cervix - An aggressive tumor with a poor prognosis: A multi-institutional study.

A. Okamoto, T. Kasamatsu, K. Ushijima, 2019, Gynecologic oncology.

Clinicopathological significance of cervical adenocarcinoma associated with lobular endocervical glandular hyperplasia.

T. Kasamatsu, H. Tsuda, K. Ushijima, 2009, Pathology, research and practice.

Angiogenesis in adenocarcinoma of the uterine cervix

N. Kinukawa, K. Ariyoshi, T. Kaku, 1998, Cancer.

Comparison of survival between upfront primary debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomized trial: JCOG0602.

A. Okamoto, T. Kasamatsu, K. Ushijima, 2018 .

Irinotecan (CPT-11) and Cisplatin as First-Line Chemotherapy for Advanced Ovarian Cancer

Y. Ohashi, N. Umesaki, S. Takeuchi, 2002, Oncology.

Non-randomized confirmatory trial of modified radical hysterectomy for patients with tumor diameter 2 cm or less FIGO Stage IB1 uterine cervical cancer: Japan Clinical Oncology Group Study (JCOG1101).

T. Kasamatsu, T. Onda, T. Kamura, 2015, Japanese journal of clinical oncology.

Endometrial carcinoma associated with hyperplasia--immunohistochemical study of angiogenesis and p53 expression.

T. Kaku, H. Nakano, T. Hirakawa, 1999, Gynecologic oncology.

Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma

D. Hori, K. Ushijima, T. Kamura, 2009, British Journal of Cancer.

Comparison of the Anterior Colporrhaphy Procedure and the Marshall‐Marchetti‐Krantz Operation in the Treatment of Stress Urinary Incontinence among Women

T. Hirakawa, H. Nakano, T. Kamura, 1999, The journal of obstetrics and gynaecology research.

Arterio‐venous fistulas involving the uterus and lung

T. Kaku, H. Nakano, T. Kamura, 1990, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Pulmonary metastasectomy for uterine cervical cancer: a multivariate analysis.

K. Shiromizu, H. Yoshikawa, T. Kamura, 2004, The Annals of thoracic surgery.

Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective study.

K. Shiromizu, H. Yoshikawa, T. Hirakawa, 2001, Gynecologic oncology.

Histopathologic prognostic factors in stage IIb cervical carcinoma treated with radical hysterectomy and pelvic-node dissection — an analysis with mathematical statistics

N. Tsukamoto, T. Kaku, H. Nakano, 1992, International Journal of Gynecologic Cancer.

Precise evaluation of chemotherapy-induced peripheral neuropathy using the visual analogue scale: a quantitative and comparative analysis of neuropathy occurring with paclitaxel–carboplatin and docetaxel–carboplatin therapy

K. Ushijima, T. Kamura, S. Takemoto, 2012, International Journal of Clinical Oncology.

Vaccination with Predesignated or Evidence-Based Peptides for Patients with Recurrent Gynecologic Cancers

K. Ushijima, H. Yamana, K. Itoh, 2004, Journal of immunotherapy.

Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505.

T. Kasamatsu, K. Ushijima, H. Yoshikawa, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic significance of epithelial-stromal vascular cuffing and microvessel density in squamous cell carcinoma of the uterine cervix.

N. Kinukawa, K. Ariyoshi, T. Kaku, 1999, Gynecologic oncology.

Validity of intraoperative diagnosis at laparoscopic surgery for ovarian tumors.

K. Ushijima, T. Kamura, A. Fukui, 2014, Journal of minimally invasive gynecology.

Desmoplastic small round cell tumor in the ovary: Report of two cases and literature review

D. Hori, K. Ushijima, T. Kamura, 2010, The journal of obstetrics and gynaecology research.

Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)

T. Kasamatsu, H. Yoshikawa, T. Yasugi, 2013, British Journal of Cancer.

Primary adenocarcinoma of the vagina successfully treated with neoadjuvant chemotherapy consisting of paclitaxel and carboplatin

K. Ushijima, T. Kamura, S. Takemoto, 2009, The journal of obstetrics and gynaecology research.

Identification of a new endoplasmic reticulum-resident protein recognized by HLA-A24-restricted tumor-infiltrating lymphocytes of lung cancer.

K. Tanaka, K. Itoh, T. Kamura, 2000, Cancer research.

Fine-needle aspiration cytology in patients with gynecologic malignancies.

H. Nakano, T. Saito, T. Kamura, 1992, Gynecologic oncology.

Cisplatin, paclitaxel and escalating doses of doxorubicin (TAP) in advanced ovarian cancer: a phase I trial.

H. Yoshikawa, T. Onda, T. Yasugi, 2004, Japanese journal of clinical oncology.

An attempt to generate an antitumor effect in the regional lymph nodes against endometrial cancer cells by inducing antitumor cytokines.

H. Nakano, T. Kamura, M. Okadome, 1996, Cancer letters.

Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma.

T. Kasamatsu, H. Tsuda, K. Ushijima, 2008, Cancer letters.

Alveolar rhabdomyosarcoma of the vulva. Report of two cases.

H. Nakano, T. Kamura, N. Tsukamoto, 1991, Acta cytologica.

Detection of Anti-tumor Activity of Lymph Node Cells Using Human Tumor Clonogenic Assay (HTCA)

H. Nakano, T. Kamura, N. Tsukamoto, 1989 .

Uterine perforation at the time of brachytherapy for the carcinoma of the uterine cervix.

T. Kamura, T. Matsuyama, N. Tsukamoto, 1986, Gynecologic oncology.

Recognition of ADP-ribosylation factor 4-like by HLA-A2-restricted and tumor-reactive cytotoxic T lymphocytes from patients with brain tumors.

M. Shigemori, S. Shichijo, K. Itoh, 2002, Tissue antigens.

GnRH agonist acts as ovarian protection in chemotherapy induced gonadotoxicity: an experiment using a rat model.

K. Ushijima, T. Kamura, A. Fukui, 2007, The Kurume medical journal.

Detection of peptide-specific CTL-precursors in peripheral blood lymphocytes of cancer patients

H. Yamana, S. Todo, M. Takahashi, 2002, British Journal of Cancer.

Lymphocytes of Lung Cancer Protein Recognized by HLA-A 24-restricted Tumor-infiltrating Identification of a New Endoplasmic Reticulum-resident Updated

Koji Tanaka, K. Itoh, T. Kamura, 2000 .

Feasibility study of personalized peptide vaccination for recurrent ovarian cancer patients

K. Ushijima, T. Sasada, K. Itoh, 2014, Immunopharmacology and immunotoxicology.

Case report Transient thyrotoxicosis following prolonged use of gonadotropin-releasing hormone agonist in women with endometriosis – a case report

T. Kamura, A. Nakashima, H. Saito, 2008 .

16 - Role of Immunohistochemical Expression of Vascular Endothelial Growth Factor C and Vascular Endothelial Growth Factor Receptor 2 in Ovarian Cancer

M. Kojiro, T. Kamura, Naoyo Nishida, 2006 .

Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma

M. Kojiro, T. Kamura, Naoyo Nishida, 2004, Cancer.

Relationship between age, histological type, and size of ovarian tumors

T Hirakawa, H. Nakano, T. Hirakawa, 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Favourable prognosis with modified dosing of docetaxel and cisplatin in Japanese patients with ovarian cancer.

Y. Ohashi, K. Hasegawa, K. Ushijima, 2009, Anticancer research.

Changes in the nitric oxide‐soluble guanylate cyclase system and natriuretic peptide receptor system in placentas of pregnant Dahl salt‐sensitive rats

D. Hori, K. Ushijima, Y. Nishi, 2015, The journal of obstetrics and gynaecology research.

Prenatal diagnosis of sustained bradycardia with 1 : 1 atrioventricular conduction

Y. Maeno, A. Hirose, D. Hori, 2003, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer.

M. Hiraoka, T. Ohno, Y. Kaneyasu, 2010, Japanese journal of clinical oncology.

Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition

Tadao Tanaka, N. Sakuragi, K. Hasegawa, 2010, International Journal of Clinical Oncology.

[Two cases of atypical polypoid adenomyoma of the uterus].

T. Kaku, H. Nakano, T. Kamura, 1993, Nihon Sanka Fujinka Gakkai zasshi.

Primary malignant melanoma arising in a cystic teratoma of the ovary.

T. Kamura, T. Matsuyama, N. Tsukamoto, 1986, Gynecologic oncology.

A prospective observational study on chemotherapy-induced nausea and vomiting (CINV) in patients with gynecologic cancer by the CINV Study Group of Japan.

F. Kikkawa, N. Yaegashi, D. Aoki, 2016, Gynecologic oncology.

Endometrial carcinoma in women aged 40 years or younger: a Japanese experience

T. Kaku, H. Nakano, T. Saito, 1992, International Journal of Gynecologic Cancer.

Prognosis of Pregnant Women with One Abnormal Value on 75g OGTT.

D. Hori, K. Ushijima, T. Horinouchi, 2014, The Kurume medical journal.

Weekly 1-h paclitaxel infusion in patients with recurrent endometrial cancer: a preliminary study

K. Ushijima, T. Kamura, T. Sugiyama, 2003, International Journal of Clinical Oncology.

Successful treatment of two patients with recurrent endometrial cancer by weekly paclitaxel.

K. Ushijima, T. Kamura, T. Sugiyama, 2000, Cancer letters.

Endolymphatic stromal myosis: a case with positive estrogen and progesterone receptors and good response to progestins.

T. Saito, T. Kamura, N. Tsukamoto, 1985, Gynecologic oncology.

The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix.

T. Kaku, T. Hirakawa, H. Nakano, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Peptide YY producing strumal carcinoid of the ovary as the cause of severe constipation with contralateral epithelial ovarian cancer

K. Ushijima, T. Kamura, K. Kawano, 2007, The journal of obstetrics and gynaecology research.

Comparison of p53, Ki-67, and CD44v6 expression between primary and matched metastatic lesions in ovarian cancer.

N. Kinukawa, K. Ariyoshi, T. Kaku, 1999, Gynecologic oncology.

Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer

H. Chung, M. Takeuchi, Byoung-Gie Kim, 2018, British Journal of Cancer.

Diffusion-weighted MR imaging in gynecologic cancers

T. Nakazono, H. Irie, S. Kudo, 2011, Journal of gynecologic oncology.

Dynamics of placental ghrelin production and its receptor expression in a Dahl salt-sensitive rat model of intrauterine growth restriction.

D. Hori, Y. Nishi, K. Kangawa, 2010, Placenta.

Outpatient Clinic for Fetal Echocardiography at the Obstetrical Department : Effect on Prenatal Diagnosis of Congenital Heart Disease

T. Matsuishi, Y. Maeno, A. Hirose, 2007 .

A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer.

C. Shimizu, Y. Fujiwara, K. Ushijima, 2012, Gynecologic oncology.

Angiogenesis in endometrial carcinoma

N. Kinukawa, M. Tsuneyoshi, S. Kawauchi, 1997, Cancer.

Breakthrough chemotherapy-induced nausea and vomiting: report of a nationwide survey by the CINV Study Group of Japan

Kazuhiro Yoshida, Y. Maehara, K. Hirata, 2017, International Journal of Clinical Oncology.

Identification of human papillomavirus 16-E6 protein-derived peptides with the potential to generate cytotoxic T-lymphocytes toward human leukocyte antigen-A24+ cervical cancer.

K. Itoh, T. Kamura, S. Matsueda, 2005, International journal of oncology.

Clinical assessment of neoadjuvant chemotherapy and interval cytoreductive surgery for unresectable advanced ovarian cancer.

K. Ushijima, T. Kamura, T. Sugiyama, 2002, International surgery.

Cyclophosphamide-induced interstitial pneumonitis in a patient with ovarian carcinoma.

T. Kamura, T. Matsuyama, N. Tsukamoto, 1984, Gynecologic oncology.

Clinicopathologic study of squamous cell carcinoma of the ovary.

T. Hirakawa, T. Kamura, M. Kashimura, 1989, Gynecologic oncology.

Angiogenesis in Cancer

M. Kojiro, T. Kamura, Naoyo Nishida, 2006, Vascular health and risk management.

Adenocarcinoma of the uterine cervix with predominantly villogladular papillary growth pattern.

T. Kaku, H. Nakano, T. Saito, 1997, Gynecologic oncology.

Short‐term estrogen test for cytodiagnosis in postmenopausal women

T. Kamura, M. Kashimura, K. Matsukuma, 1987, Diagnostic cytopathology.

Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: an international collaborative meta-analysis.

J. W. Kim, H. Cai, T. Kamura, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Lymph nodes in gynecologic oncology: Enduring importance and challenge

T. Kamura, 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

A randomized, phase III trial of paclitaxel plus carboplatin (TC) versus paclitaxel plus cisplatin (TP) in stage IVb, persistent or recurrent cervical cancer: Japan Clinical Oncology Group study (JCOG0505).

K. Ushijima, H. Yoshikawa, M. Takano, 2012 .